kabutan

RaQualia Pharma Inc.(4579) Summary

4579
TSE Growth
RaQualia Pharma Inc.
873
JPY
-6
(-0.68%)
Mar 13, 3:30 pm JST
5.47
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
875
Mar 13, 11:46 pm JST
Summary Chart Historical News Financial Result
PER
PBR
3.32
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:03 am
855 JPY 5.37 USD
Previous Close Mar 12
879 JPY 5.52 USD
High Mar 13, 10:33 am
876 JPY 5.50 USD
Low Mar 13, 9:09 am
850 JPY 5.34 USD
Volume
296,100
Trading Value
0.26B JPY 1.61M USD
VWAP
864.78 JPY 5.43 USD
Minimum Trading Value
87,300 JPY 547 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
545
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
1,419
1-Year High Dec 2, 2025
41,024
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 600 2,791,300 4652.17
Feb 27, 2026 0 3,006,100
Feb 20, 2026 0 3,138,700
Feb 13, 2026 400 3,132,400 7831.00
Feb 6, 2026 900 3,275,900 3639.89
Company Profile
RaQualia Pharma Inc. is a drug discovery venture company specializing in pain disorders. Its main revenue source is the out-licensing of intellectual property rights for drug candidates.
Sector
Pharmaceuticals
RaQualia Pharma Inc. is a research and development-oriented drug discovery venture with a business model focused on out-licensing intellectual property rights of novel drug candidates to pharmaceutical companies. The company conducts drug discovery research and development for high-need medical conditions, primarily in gastrointestinal and pain disorders. RaQualia Pharma Inc. pursues agile and flexible business activities, offering its entire research and development portfolio for out-licensing at various stages, from early exploration to clinical development. The company actively engages in open innovation-based research and development, addressing a wide range of disease areas through industry-academic collaborations. RaQualia Pharma Inc. has built a research and development portfolio comprising multiple projects, including out-licensing preparation programs, out-licensed programs, and collaborative research programs.